Share

November 2019; 6 (6) EditorialOpen Access

Untangling normal aging from disease-related brain atrophy in MS

Tim Sinnecker, Jens Wuerfel
First published September 25, 2019, DOI: https://doi.org/10.1212/NXI.0000000000000617
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
115

Share

Article Information

vol. 6 no. 6 e617
DOI: 
https://doi.org/10.1212/NXI.0000000000000617
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received July 31, 2019
  • Accepted in final form August 19, 2019
  • First Published September 25, 2019.
Copyright & Usage: 
Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Tim Sinnecker, MD and
    2. Jens Wuerfel, MD
  1. Tim Sinnecker, MD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Commercial entity, travel support from Actelion. (2) Commercial entity, travel support from Roche. (3) Commercial entity, speaker fees from Biogen.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. (1) non-profit entity, Medical Image Analysis Center Basel, part-time employee, research associate, three years

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Jens Wuerfel, MD
    3. Scientific Advisory Boards:

    1. 2017: Genzyme, Roche advisory board 2018: Roche, Novartis advisory board 2019: Roche advisory board

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 2012-2016: Bayer, Biogen, Novartis speaker honoraria

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. CEO, MIAC AG, Switzerland (non-profit organisation)

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. German ministry of education and research (BMBF/KKNMS), subinvestigator, 2013-2016; and the German ministry of economy (BMWi), EXIST program and EU (Horizon2020)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Medicine (T.S.), Neurologic Clinic and Policlinic, University Hospital Basel and University of Basel; qbig (T.S., J.W.), Department of Medicine and Biomedical Engineering, University Hospital Basel and University of Basel; Medical Image Analysis Center Basel AG (T.S., J.W.); and Translational Imaging in Neurology [ThINK] Basel (T.S.), Department of Medicine and Biomedical Engineering, University Hospital Basel and University of Basel, Switzerland.
  1. Correspondence
    Dr. Sinnecker Tim.Sinnecker{at}usb.ch
View Full Text

Article usage

Article usage: September 2019 to January 2020

AbstractFullPdfSource
Sep 201915629Highwire
Oct 201986930Highwire
Nov 2019816542Highwire
Dec 20195465Highwire
Jan 20202529Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.nn.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Letters

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Letters Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

Related Articles

Topics Discussed

Alert Me

Advertisement